761 related articles for article (PubMed ID: 18839076)
1. Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics.
Sumiyoshi T; Bubenikova-Valesova V; Horacek J; Bert B
Adv Ther; 2008 Oct; 25(10):1037-56. PubMed ID: 18839076
[TBL] [Abstract][Full Text] [Related]
2. Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia?
Meltzer HY; Sumiyoshi T
Behav Brain Res; 2008 Dec; 195(1):98-102. PubMed ID: 18707769
[TBL] [Abstract][Full Text] [Related]
3. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors.
Hagiwara H; Fujita Y; Ishima T; Kunitachi S; Shirayama Y; Iyo M; Hashimoto K
Eur Neuropsychopharmacol; 2008 Jun; 18(6):448-54. PubMed ID: 18164909
[TBL] [Abstract][Full Text] [Related]
4. The role of 5-HT(1A) receptors in learning and memory.
Ogren SO; Eriksson TM; Elvander-Tottie E; D'Addario C; Ekström JC; Svenningsson P; Meister B; Kehr J; Stiedl O
Behav Brain Res; 2008 Dec; 195(1):54-77. PubMed ID: 18394726
[TBL] [Abstract][Full Text] [Related]
5. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
6. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets.
Terry AV; Buccafusco JJ; Wilson C
Behav Brain Res; 2008 Dec; 195(1):30-8. PubMed ID: 18241938
[TBL] [Abstract][Full Text] [Related]
7. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
Meltzer HY; Huang M
Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
[TBL] [Abstract][Full Text] [Related]
8. 5-HT(7) receptors in the modulation of cognitive processes.
Cifariello A; Pompili A; Gasbarri A
Behav Brain Res; 2008 Dec; 195(1):171-9. PubMed ID: 18243350
[TBL] [Abstract][Full Text] [Related]
9. Learning and memory in 5-HT(1A)-receptor mutant mice.
Bert B; Fink H; Rothe J; Walstab J; Bönisch H
Behav Brain Res; 2008 Dec; 195(1):78-85. PubMed ID: 18396339
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist.
Piskulić D; Olver JS; Maruff P; Norman TR
Hum Psychopharmacol; 2009 Aug; 24(6):437-46. PubMed ID: 19637398
[TBL] [Abstract][Full Text] [Related]
11. Influence of social isolation in the rat on serotonergic function and memory--relevance to models of schizophrenia and the role of 5-HT₆ receptors.
Marsden CA; King MV; Fone KC
Neuropharmacology; 2011 Sep; 61(3):400-7. PubMed ID: 21414329
[TBL] [Abstract][Full Text] [Related]
12. Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT(1A) receptor activation.
Schreiber R; Newman-Tancredi A
Neurobiol Learn Mem; 2014 Apr; 110():72-80. PubMed ID: 24423786
[TBL] [Abstract][Full Text] [Related]
13. Serotonin 1A receptors in memory function.
Sumiyoshi T; Meltzer HY
Am J Psychiatry; 2004 Aug; 161(8):1505; author reply 1505-6. PubMed ID: 15285993
[No Abstract] [Full Text] [Related]
14. Correlating efficacy in rodent cognition models with in vivo 5-hydroxytryptamine1a receptor occupancy by a novel antagonist, (R)-N-(2-methyl-(4-indolyl-1-piperazinyl)ethyl)-N-(2-pyridinyl)-cyclohexane carboxamide (WAY-101405).
Hirst WD; Andree TH; Aschmies S; Childers WE; Comery TA; Dawson LA; Day M; Feingold IB; Grauer SM; Harrison BL; Hughes ZA; Kao J; Kelly MG; van der Lee H; Rosenzweig-Lipson S; Saab AL; Smith DL; Sullivan K; Rizzo SJ; Tio C; Zhang MY; Schechter LE
J Pharmacol Exp Ther; 2008 Apr; 325(1):134-45. PubMed ID: 18182558
[TBL] [Abstract][Full Text] [Related]
15. Allosteric modulation of 5-HT(1A) receptors by zinc: Binding studies.
Barrondo S; Sallés J
Neuropharmacology; 2009 Feb; 56(2):455-62. PubMed ID: 18951909
[TBL] [Abstract][Full Text] [Related]
16. Lurasidone: a new drug in development for schizophrenia.
Meyer JM; Loebel AD; Schweizer E
Expert Opin Investig Drugs; 2009 Nov; 18(11):1715-26. PubMed ID: 19780705
[TBL] [Abstract][Full Text] [Related]
17. Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development.
Marek GJ
Int Rev Neurobiol; 2007; 78():165-92. PubMed ID: 17349861
[TBL] [Abstract][Full Text] [Related]
18. Distribution of 5-HT and DA receptors in primate prefrontal cortex: implications for pathophysiology and treatment.
de Almeida J; Palacios JM; Mengod G
Prog Brain Res; 2008; 172():101-15. PubMed ID: 18772029
[TBL] [Abstract][Full Text] [Related]
19. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta.
Sumiyoshi T; Higuchi Y; Itoh T; Matsui M; Arai H; Suzuki M; Kurachi M; Sumiyoshi C; Kawasaki Y
Psychiatry Res; 2009 Jun; 172(3):180-3. PubMed ID: 19386475
[TBL] [Abstract][Full Text] [Related]
20. 5-HT(1A) receptors in the frontal cortical brain areas in Cloninger type 1 and 2 alcoholics measured by whole-hemisphere autoradiography.
Storvik M; Häkkinen M; Tupala E; Tiihonen J
Alcohol Alcohol; 2009; 44(1):2-7. PubMed ID: 19029097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
